about
NetPath: a public resource of curated signal transduction pathwaysHLA-F is a surface marker on activated lymphocytesCD8+ T cell immunity against a tumor/self-antigen is augmented by CD4+ T helper cells and hindered by naturally occurring T regulatory cells.IL-15 induces CD4 effector memory T cell production and tissue emigration in nonhuman primatesThe melatonin-cytokine connection in rheumatoid arthritisThe quantal theory of how the immune system discriminates between "self and non-self"Adoptive T cell therapy: Addressing challenges in cancer immunotherapyExpression of cytokine mRNA and protein in joints and lymphoid organs during the course of rat antigen-induced arthritismTOR inhibitors effects on regulatory T cells and on dendritic cellsNK Cell and CD4+FoxP3+ Regulatory T Cell Based Therapies for Hematopoietic Stem Cell EngraftmentApplication of IL-2 therapy to target T regulatory cell functionInsights into cytokine-receptor interactions from cytokine engineeringFrom tumor immunosuppression to eradication: targeting homing and activity of immune effector cells to tumorsIL-2/anti-IL-2 mAb immunocomplexes: A renascence of IL-2 in cancer immunotherapy?Differential responses of human regulatory T cells (Treg) and effector T cells to rapamycinTherapeutic enhancement of protective immunity during experimental leishmaniasisA pilot study of IL-2Rα blockade during lymphopenia depletes regulatory T-cells and correlates with enhanced immunity in patients with glioblastomaIn vivo expansion of naïve CD4+ CD25(high) FOXP3+ regulatory T cells in patients with colorectal carcinoma after IL-2 administrationSystemic lupus erythematosus serum IgG increases CREM binding to the IL-2 promoter and suppresses IL-2 production through CaMKIVOpinion: Satisfaction (not) guaranteed: re-evaluating the use of animal models of type 1 diabetesA novel role of IL-2 in organ-specific autoimmune inflammation beyond regulatory T cell checkpoint: both IL-2 knockout and Fas mutation prolong lifespan of Scurfy mice but by different mechanismsIL-2: a two-faced master regulator of autoimmunityGenetics of type 1 diabetes: what's next?SHP-1 and SHP-2 in T cells: two phosphatases functioning at many levelsConstruction, purification, and characterization of a chimeric TH1 antagonist.Digital NFATc2 activation per cell transforms graded T cell receptor activation into an all-or-none IL-2 expression.A population dynamics analysis of the interaction between adaptive regulatory T cells and antigen presenting cells.Resting regulatory CD4 T cells: a site of HIV persistence in patients on long-term effective antiretroviral therapyIL2RA genetic heterogeneity in multiple sclerosis and type 1 diabetes susceptibility and soluble interleukin-2 receptor production.T cell-intrinsic role of Nod2 in promoting type 1 immunity to Toxoplasma gondii.Targeting Janus tyrosine kinase 3 (JAK3) with an inhibitor induces secretion of TGF-β by CD4+ T cells.Decrease of Foxp3+ Treg cell number and acquisition of effector cell phenotype during lethal infectionCurrent and future approaches for control of graft-versus-host disease.Indoleamine 2,3-dioxygenase 1 (IDO1) activity in leukemia blasts correlates with poor outcome in childhood acute myeloid leukemia.IL-2 mediates CD4+ T cell help in the breakdown of memory-like CD8+ T cell tolerance under lymphopenic conditionsAllogeneic T regulatory cell-mediated transplantation tolerance in adoptive therapy depends on dominant peripheral suppression and central tolerance.The association of -330 interleukin-2 gene polymorphism with its plasma concentration in Iranian multiple sclerosis patients.Apoptosis of purified CD4+ T cell subsets is dominated by cytokine deprivation and absence of other cells in new onset diabetic NOD mice.Interleukin-2 receptor downstream events in regulatory T cells: implications for the choice of immunosuppressive drug therapyLocalization of a type 1 diabetes locus in the IL2RA/CD25 region by use of tag single-nucleotide polymorphisms.
P2860
Q21184104-A5738921-6B20-4EA1-8926-3FD5795CD13CQ24300864-7E37320F-13E2-49F6-9874-A07F762D4A87Q24540429-0A1F5E5B-A4E8-4142-AA56-261D7605A71AQ24547172-36642081-F3B8-46F8-88F8-C3B9F9A686BBQ24673291-A815256B-329E-4667-BDBF-B05E675659E8Q24803143-F8738CBC-FACA-49FF-B182-F63E1C9603EBQ24805804-7F427182-830A-4D31-83B4-FDC852B2C7EFQ24816530-66B04450-B121-401B-9328-EF766A5F7306Q26744447-9BA10BEC-2E57-43E1-A10E-ABB755B3D829Q26765845-49C2F8C5-9798-445D-A75B-33CDE5060966Q26827327-B5E1299B-D19F-4583-9BB8-F9E0635C218BQ26852703-B43B35A7-8A6F-4EBE-B951-CB81E863BFBBQ26865532-831EE592-AC14-4171-831D-54B4E5F40FC3Q28073154-2DDB98D0-5D90-4872-BB3F-D32E66186F94Q28475626-F0FFA7D3-EA8A-4A51-A717-B9D6B38C9C7BQ28476803-A426D1E9-EEF3-4AE3-9195-6BA0169B08EAQ28731711-2E2B38B2-61AE-4272-B7C2-32AE47F237D5Q28732675-91FD24A3-4B29-48A2-AF45-7ABFC6ABC96FQ28972565-C13F2C08-FFB7-480D-8894-B88EF267C0A5Q29393228-AC103326-84BB-47FC-BB16-8EC72C9E251DQ30423284-7917026D-E46B-4D0F-932A-16705440FBAFQ30428106-83BD256A-EBA5-4068-90A3-A09836D3FDD3Q30431554-C0D16341-1259-45EB-AD6F-A958BF5D86EAQ30436912-10D2F509-447D-4FF0-887C-455D85A52D07Q33244262-66C5281A-BAB0-43DA-8835-19B1EED7D5A8Q33300337-80A90A28-E8CF-427B-89CE-E306C8952513Q33338436-C4760FF5-3267-4E35-92C2-CC47BAA34516Q33373073-493892AD-610E-4AFF-8A61-D19263D4DCCEQ33396971-D661BE69-F5F8-49CF-A5C2-4E2091E97CA3Q33577143-AAAF7A15-70A1-4CC3-A007-C9E8EBCDBA1DQ33577441-1BC35841-80BF-4C72-9AF8-717193106448Q33624096-B62912A2-2BD1-40D9-A817-A55593FF859DQ33642625-BC02A5BD-43BC-42D6-AA44-258AD0D90913Q33688517-2E7A5A9B-0CD6-469E-A16D-2AA565FEB7F6Q33697777-40EFE53F-10AD-488F-89C5-6425C3EDAE55Q33722667-EA210249-C238-47B4-8FAC-CC2783461E7AQ33736320-33AF65AA-6B34-447C-9280-5B1F2ACB12B8Q33786819-6FD7E739-9059-45B3-8CF2-F60C2AF9B845Q33917765-28CD3E16-7F11-4C07-8375-E1D2C12B57AAQ33942274-0123F26D-DEB7-4BEC-8314-62FFB726D7CB
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Tolerance, not immunity, crucially depends on IL-2.
@ast
Tolerance, not immunity, crucially depends on IL-2.
@en
type
label
Tolerance, not immunity, crucially depends on IL-2.
@ast
Tolerance, not immunity, crucially depends on IL-2.
@en
prefLabel
Tolerance, not immunity, crucially depends on IL-2.
@ast
Tolerance, not immunity, crucially depends on IL-2.
@en
P356
P1476
Tolerance, not immunity, crucially depends on IL-2
@en
P2093
Thomas R Malek
P304
P356
10.1038/NRI1435
P577
2004-09-01T00:00:00Z